Pirtobrutinib Targets BTK C481S in Ibrutinib-Resistant CLL but Second-Site BTK Mutations Lead to Resistance
Aishath Naeem,Filippo Utro,Qing Wang,Justin Cha,Mauno Vihinen,Stephen Martindale,Yinglu Zhou,Yue Ren,Svitlana Tyekucheva,Annette S. Kim,Stacey M. Fernandes,Gordon Saksena,Kahn Rhrissorrakrai,Chaya Levovitz,Brian P. Danysh,Kara Slowik,Raquel A. Jacobs,Matthew S. Davids,James A. Lederer,Rula Zain,C. I. Edvard Smith,Ignaty Leshchiner,Laxmi Parida,Gad Getz,Jennifer R. Brown BLOOD ADVANCES（2023）
AI 理解论文
溯源树
样例
